Loading clinical trials...
Loading clinical trials...
This trial pursues studying a compassionate treatment option for patients with inoperable pseudomyxoma peritonei through percutaneous administration of bromelain + N-acetylcysteine (NAC) in order to d...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Maimónides Biomedical Research Institute of Córdoba
NCT01617382 · Peritoneal Carcinomatosis, Pseudomyxoma Peritonei, and more
NCT06084780 · Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, and more
NCT06839378 · Pseudomyxoma Peritonei
NCT02040142 · Peritoneal Carcinomatosis, Colorectal Cancer, and more
NCT02599116 · Pseudomyxoma Peritonei, Appendiceal Neoplasm, and more
Hospital Universitario Reina Sofía
Córdoba
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions